Cuneiform Nucleus (Cnf) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Taxonomy | ID | Name / Label |
|---|
The Cuneiform Nucleus (CnF) is located in the midbrain tegmentum and is part of the mesencephalic locomotor region (MLR). This nucleus plays important roles in locomotion, arousal, and postural control. [1]
Key characteristics include: [2]
The cuneiform nucleus is implicated in Parkinson's disease (freezing of gait), progressive supranuclear palsy, and other movement disorders affecting the mesencephalon. [3]
Cuneiform Nucleus (CnF) is a specialized neuronal population involved in locomotion and pain modulation. These neurons play critical roles in motor control and arousal and are vulnerable in various neurodegenerative diseases. [4]
The Cuneiform Nucleus (CnF) is structure a prominent in the midbrain reticular formation that plays a critical role in arousal, locomotor control, and sleep-wake regulation. It is one of the key mesopontine tegmental nuclei involved in modulating behavioral states and motor output. [5]
| Attribute | Value | [6]
|-----------|-------| [7]
| Full Name | Cuneiform Nucleus |
| Abbreviation | CnF |
| Location | Midbrain, dorsal tegmentum, between the superior cerebellar peduncle and the lateral lemniscus |
| Cell Type | Mixed glutamatergic and GABAergic neurons |
| Allen Atlas ID | Mouse: 1053 |
| Neurotransmitter | Glutamate, GABA |
The Cuneiform Nucleus contains heterogeneous neuronal populations characterized by:
Key molecular markers for CnF neurons include:
The Cuneiform Nucleus is a key component of the ascending reticular activating system (ARAS):
CnF plays an important role in modulating locomotion:
Key differentially expressed genes in Cuneiform Nucleus neurons (from Allen Brain Atlas):
| Gene | Expression Level | Function |
|---|---|---|
| Vglut2 (Slc17a6) | High | Glutamate neurotransmission |
| Gad2 | Moderate | GABA synthesis |
| Grp (Gastrin Releasing Peptide) | Moderate | Neuropeptide signaling |
| Nts (Neurotensin) | Moderate | Neuromodulation |
| Cartpt (CART) | Low-Moderate | Appetite and energy regulation |
| Th (Tyrosine Hydroxylase) | Low | Dopamine synthesis (subset) |
Thalamic relay nuclei (intralaminar, midline)
Basal forebrain cholinergic nuclei
Pontine reticular formation
Spinal cord (reticulospinal tract)
Pedunculopontine Nucleus
Sublaterodorsal Nucleus
Reticular Formation
REM Sleep Behavior Disorder
The study of Cuneiform Nucleus (Cnf) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Rye DB. Contribution of the pedunculopontine region to normal and altered REM sleep. Sleep. 1997. ↩︎
Benarroch EE. The midline and intralaminar thalamic nuclei: anatomic, functional, and clinical correlates. Neurology. 2008. ↩︎
Jellinger KA. Neuropathology of multiple system atrophy: new thoughts about pathogenesis. Mov Disord. 2014. ↩︎
Grinberg LT, Rueb U, Alho AT, et al. Brainstem serotonin deficiency in progressive supranuclear palsy. Mov Disord. 2010. ↩︎
Garcia-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, et al. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain. 2013. ↩︎
Saper CB, Fuller PM, Pedersen NP, et al. Sleep state switching. Neuron. 2010. ↩︎
Mesulam MM. Cholinergic circuitry of the human nucleus basalis and its fate in aging and Alzheimer's disease. J Comp Neurol. 2013. ↩︎